$GILD insider trading

Over the last 12 months, Gilead Sciences insiders reported no purchases and 9 sales totaling $7.3M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.

$7.3M
9
3
100%
Side
$100K$1.0M$10MJun '26JulAug
O'Day Daniel Patrick
Mercier Johanna
Dickinson Andrew D

All insider trades

Aug 3, 2026O'Day Daniel Patrick▼ Sale15,000$130.31$2.0M-2.5%
Jul 15, 2026Dickinson Andrew D▼ Sale3,000$129.93$390K-1.7%
Jul 15, 2026Mercier Johanna▼ Sale3,000$129.92$390K-2.4%
Jul 1, 2026O'Day Daniel Patrick▼ Sale15,000$126.29$1.9M-2.4%
Jun 15, 2026Mercier Johanna▼ Sale3,000$123.92$372K-2.4%
Jun 15, 2026Dickinson Andrew D▼ Sale3,000$125.4$376K-1.7%
Jun 1, 2026O'Day Daniel Patrick▼ Sale1,038$132.97$138K-0.2%
Jun 1, 2026O'Day Daniel Patrick▼ Sale3,062$132.22$405K-0.5%
Jun 1, 2026O'Day Daniel Patrick▼ Sale10,900$131.1$1.4M-1.7%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $GILD feed.

GILD Insider Trading — Form 4 Buys & Sells | alphai